Tenax Therapeutics Ownership | Who Owns Tenax Therapeutics?
Tenax Therapeutics Ownership Summary
Tenax Therapeutics is owned by 59.77% institutional investors, 0.11% insiders, and 40.12% retail investors. Price t rowe associates inc /md/ is the largest institutional shareholder, holding 7.53% of TENX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.21% of its assets in Tenax Therapeutics shares.
TENX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Tenax Therapeutics | 59.77% | 0.11% | 40.12% |
| Sector | Healthcare Stocks | 246.48% | 12.12% | -158.60% |
| Industry | Biotech Stocks | 384.82% | 11.76% | -296.58% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Price t rowe associates inc /md/ | 2.95M | 7.53% | $47.19M |
| Janus henderson group | 1.82M | 4.63% | $29.07M |
| Perceptive advisors | 1.45M | 3.69% | $23.15M |
| Ikarian capital | 1.02M | 2.59% | $16.27M |
| Stonepine capital management | 975.20K | 2.49% | $15.59M |
| Logos global management lp | 625.00K | 1.59% | $9.99M |
| Morgan stanley | 596.56K | 1.52% | $9.54M |
| Velan capital investment management lp | 583.33K | 1.49% | $9.33M |
| Adage capital partners gp | 540.13K | 1.38% | $8.64M |
| Point72 asset management | 533.97K | 1.36% | $8.54M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Stonepine capital management | 975.20K | 6.24% | $15.59M |
| Velan capital investment management lp | 583.33K | 5.84% | $9.33M |
| Verdad advisers, lp | 95.33K | 1.72% | $1.52M |
| Ikarian capital | 1.02M | 1.32% | $16.27M |
| Avidity partners management lp | 265.93K | 0.79% | $3.49M |
| Stempoint capital lp | 188.70K | 0.59% | $3.02M |
| Logos global management lp | 625.00K | 0.50% | $9.99M |
| Perceptive advisors | 1.45M | 0.45% | $23.15M |
| Sphera funds management | 136.01K | 0.35% | $2.17M |
| Vivo capital | 208.33K | 0.28% | $3.33M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Price t rowe associates inc /md/ | 2.95M | 0.01% | 2.95M |
| Janus henderson group | 1.82M | 0.01% | 1.65M |
| Perceptive advisors | 1.45M | 0.45% | 1.01M |
| Stonepine capital management | 975.20K | 6.24% | 963.32K |
| Logos global management lp | 625.00K | 0.50% | 625.00K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Vr adviser | - | - | -1.68M |
| Armistice capital | - | - | -478.83K |
| Great point partners | - | - | -327.31K |
| Ameriprise financial | - | - | -279.54K |
| Boone capital management | - | - | -200.00K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Price t rowe associates inc /md/ | 2.95M | 0.01% | 2.95M | $47.19M |
| Logos global management lp | 625.00K | 0.50% | 625.00K | $9.99M |
| Td asset management | 399.18K | 0.01% | 399.18K | $6.38M |
| Avidity partners management lp | 265.93K | 0.79% | 265.93K | $3.49M |
| Stempoint capital lp | 188.70K | 0.59% | 188.70K | $3.02M |
Sold Out
| Holder | Change |
|---|---|
| Wealthspire advisors | -1.00 |
| Mai capital management | -1.00 |
| Sbi securities | -2.00 |
| Commonwealth retirement investments | -2.00 |
| Nisa investment advisors | -500.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 129 | 59.26% | 30,406,207 | 43.25% | 59 | 2.71% | 87 | 47.46% | 16 | 220.00% |
| Mar 31, 2026 | 19 | -60.42% | 1,573,538 | -77.36% | 4 | 1.31% | 13 | -58.06% | 1 | -66.67% |
| Dec 31, 2025 | 19 | -44.12% | 2,128,813 | -54.91% | 5 | 3.76% | 14 | -30.00% | - | -100.00% |
| Sep 30, 2025 | 33 | 32.00% | 4,720,737 | 111.51% | 11 | 37.50% | 20 | 150.00% | 2 | -50.00% |
| Jun 30, 2025 | 25 | 8.70% | 2,231,961 | 11.24% | 5 | 18.75% | 8 | -11.11% | 4 | 33.33% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 852.26K | 3.21% | 658.10K |
| Vanguard Morn Total Stk Mkt Idx Investor | 852.26K | 3.21% | 658.10K |
| Fidelity Select Biotechnology | 969.20K | 2.59% | - |
| iShares Russell 2000 ETF | 923.46K | 2.47% | -10.62K |
| FIAM Small Cap Core CIT Cl B | 627.58K | 2.37% | 627.58K |
| Vanguard MStar Total Stk Mkt Idx Invest | 852.26K | 2.28% | - |
| RTW Biotech Opportunities Ord | 772.76K | 2.06% | 772.76K |
| T. Rowe Price Health Sciences | 445.98K | 1.68% | -1.94M |
| Strategic Advisers Fidelity US TtlStk | 515.19K | 1.38% | - |
| Fidelity Advisor Biotechnology I | 445.10K | 1.19% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Oct 20, 2026 | ADAR1 Capital Management, LLC | - | Buy | $405.73K |
| Oct 21, 2026 | ADAR1 Capital Management, LLC | - | Buy | $550.69K |
| Oct 19, 2026 | ADAR1 Capital Management, LLC | - | Buy | $507.01K |
| Sep 16, 2026 | Doogan Declan | - | Buy | $101.76K |
| Sep 15, 2026 | Giordano Christopher Thomas | CEO | Buy | $8.84K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q4 | 3 | - |
| 2026 Q3 | 11 | - |
| 2026 Q2 | - | - |
| 2026 Q1 | - | - |
| 2025 Q4 | 13 | - |
TENX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools